Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Novartis
Mallinckrodt
Citi
US Department of Justice
Colorcon
Teva
Chinese Patent Office
Queensland Health
Healthtrust

Generated: August 17, 2017

DrugPatentWatch Database Preview

MIDODRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Midodrine Hydrochloride, and when can generic versions of Midodrine Hydrochloride launch?

Midodrine Hydrochloride is a drug marketed by Sandoz, Apotex Inc, Impax Pharms, and Mylan Pharms Inc. and is included in four NDAs.

The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

Summary for Tradename: MIDODRINE HYDROCHLORIDE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list15
Bulk Api Vendors: see list36
Clinical Trials: see list2,299
Patent Applications: see list226
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MIDODRINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: MIDODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076514-001Sep 11, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076449-001May 27, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL077746-001Sep 12, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076577-003Sep 10, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076449-002May 27, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Novartis
Chinese Patent Office
Cantor Fitzgerald
Accenture
Express Scripts
Johnson and Johnson
UBS
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot